Cited by 767Glioma Diagnosis and TreatmentCancer-related Molecular PathwaysNeurogenesis and neuroplasticity mechanisms

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation

Open access

Zheng, Hongwu, Ying, Haoqiang, Yan, Haiyan, Kimmelman, Alec C., Hiller, David J., Chen, An-Jou, Perry, Samuel R., Tonon, Giovanni, Chu, Gerald C., Ding, Zhihu, Stommel, Jayne M., Dunn, Katherine L., Wiedemeyer, Ruprecht, You, Mingjian J., Brennan, Cameron, Wang, Y. Alan, Ligon, Keith L., Wong, Wing H., Chin, Lynda, DePinho, Ronald A.·2008·Nature

DOI 10.1038/nature07443PMC PMC4051433

Open this paper in CoChat — free account

Abstract

Glioblastoma (GBM) is a highly lethal brain tumour presenting as one of two subtypes with distinct clinical histories and molecular profiles. The primary GBM subtype presents acutely as a high-grade disease that typically harbours mutations in EGFR, PTEN and INK4A/ARF (also known as CDKN2A), and the secondary GBM subtype evolves from the slow progression of a low-grade disease that classically possesses PDGF and TP53 events. Here we show that concomitant central nervous system (CNS)-specific deletion of p53 and Pten in the mouse CNS generates a penetrant acute-onset high-grade malignant glioma phenotype with notable clinical, pathological and molecular resemblance to primary GBM in humans. This genetic observation prompted TP53 and PTEN mutational analysis in human primary GBM, demonstrating unexpectedly frequent inactivating mutations of TP53 as well as the expected PTEN mutations. Integrated transcriptomic profiling, in silico promoter analysis and functional studies of murine neural stem cells (NSCs) established that dual, but not singular, inactivation of p53 and Pten promotes an undifferentiated state with high renewal potential and drives increased Myc protein levels and its associated signature. Functional studies validated increased Myc activity as a potent contributor to the impaired differentiation and enhanced renewal of NSCs doubly null for p53 and Pten (p53(-/-) Pten(-/-)) as well as tumour neurospheres (TNSs) derived from this model. Myc also serves to maintain robust tumorigenic potential of p53(-/-) Pten(-/-) TNSs. These murine modelling studies, together with confirmatory transcriptomic/promoter studies in human primary GBM, validate a pathogenetic role of a common tumour suppressor mutation profile in human primary GBM and establish Myc as an important target for cooperative actions of p53 and Pten in the regulation of normal and malignant stem/progenitor cell differentiation, self-renewal and tumorigenic potential.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature07443

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,656
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Self-citation
Erratum to: The 2007 WHO classification of tumours of the central nervous system
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-156115 · Cited by 4,435
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133
Self-citation
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C., Jamieson, C., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,124
An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
Self-citation
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityPreprint
Sears, R. C., Nuckolls, F., Haura, E. B., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,411

Flagged first, then by citations

Show all 37 references

Sorted by citations

Items 101–200 of 759

FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
Gan, B., Lim, C., Chu, G., Hua, S., Ding, Z., Collins, M. P., HU, J. L., Jiang, S., Fletcher-Sananikone, E., Zhuang, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.019 · Cited by 149
Self-citation
Glioblastoma Models Reveal the Connection between Adult Glial Progenitors and the Proneural Phenotype
Lei, L., Sonabend, A. M., Guarnieri, P., Soderquist, C. R., Ludwig, T. E., Rosenfeld, S. A., Bruce, J. N., & Canoll, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020041 · Cited by 149
PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3
Benítez, J. A., Ma, J., D’Antonio, M., Boyer, A. D., Camargo, M. F., Zanca, C., Kelly, S., Khodadadi‐Jamayran, A., Jameson, N. M., Andersen, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15223 · Cited by 147
Brain tumor stem cells: The cancer stem cell hypothesis writ large
Dirks, P. B. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.08.001 · Cited by 144
β2-Microglobulin Maintains Glioblastoma Stem Cells and Induces M2-like Polarization of Tumor-Associated Macrophages
Li, D., Zhang, Q., Li, L., Chen, K., Yang, J., Dixit, D., Gimple, R. C., Ci, S., Lu, C., Hu, L., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0507 · Cited by 142
MicroRNA-17-92 Cluster Mediates the Proliferation and Survival of Neural Progenitor Cells after Stroke
Liu, X., Chopp, M., Wang, X. L., Zhang, L., Hozeska‐Solgot, A., Tang, T., Kassis, H., Zhang, R. L., Chen, C., Xu, J. W., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.449025 · Cited by 138
Glioblastoma: A Pathogenic Crosstalk between Tumor Cells and Pericytes
Caspani, E. M., Crossley, P. H., Redondo-Garcia, C., & Martı́nez, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101402 · Cited by 144
A miR‐34a‐SIRT6 axis in the squamous cell differentiation network
Lefort, K., Brooks, Y., Ostano, P., Cario, M., Calpini, V., Guinea‐Viniegra, J., Albinger‐Hegyi, A., Hoetzenecker, W., Kolfschoten, I., Wagner, E. F., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.156 · Cited by 138
Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding
Sami, A., & Karsy, M. J. (2013) · Tumor Biology · doi:10.1007/s13277-013-0800-5 · Cited by 137
Metabolic alterations in cancer cells and therapeutic implications
Hammoudi, N., Ahmed, K. B. R., Garcı́a-Prieto, C., & Huang, P. (2011) · 癌症：英文版 · doi:10.5732/cjc.011.10267 · Cited by 137
Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma
Kaur, N., Chettiar, S. T., Rathod, S. S., Rath, P., Muzumdar, D., Shaikh, M. L., & Shiras, A. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.01.001 · Cited by 133
Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5APreprint
Hubert, C. G., Bradley, R. K., Ding, Y., Toledo, C. M., Herman, J., Skutt-Kakaria, K., Girard, E. J., Davison, J., Berndt, J. D., Corrin, P. D., et al. (2013) · Genes & Development · doi:10.1101/gad.212548.112 · Cited by 134
WIP1 phosphatase at the crossroads of cancer and aging
Guezennec, X. L., & Bulavin, D. V. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.09.005 · Cited by 135
An RNAi Screen Identifies TRRAP as a Regulator of Brain Tumor-Initiating Cell Differentiation
Wurdak, H., Zhu, S., Romero, A., Lorger, M., Watson, J., Chiang, C.-Y., Zhang, J., Natu, V. S., Lairson, L. L., Walker, J. R., et al. (2010) · Cell stem cell · doi:10.1016/j.stem.2009.11.002 · Cited by 137
EZH2 Palmitoylation Mediated by ZDHHC5 in p53-Mutant Glioma Drives Malignant Development and Progression
Chen, X., Ma, H., Wang, Z., Zhang, S., Yang, H., & Fang, Z. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1139 · Cited by 131
A renewed concept on the MAPK signaling pathway in cancers: Polyphenols as a choice of therapeutics
Anjum, J., Mitra, S., Das, R. C., Alam, R., Mojumder, A., Emran, T. B., Islam, F., Rauf, A., Hossain, M. J., Aljohani, A. S. M., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106398 · Cited by 129
Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process
Galvão, R. P., Kasina, A., McNeill, R. S., Harbin, J. E., Foreman, O., Verhaak, R. G. W., Nishiyama, A., Miller, C. R., & Zong, H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414389111 · Cited by 136
Notch Signaling in Cancer Stem Cells
Wang, J., Sullenger, B. A., & Rich, J. N. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_13 · Cited by 127
Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency
Guo, S., Ye, H., Teng, Y., Wang, Y.-L., Yang, G., Li, X.-B., Zhang, C., Yang, X., Yang, Z., & Yang, X. Y. (2013) · Nature Communications · doi:10.1038/ncomms3544 · Cited by 126
Self-citation
Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas
Italiano, A., Chen, C., Thomas, R. J., Breen, M., Bonnet, F., Sévenet, N., Longy, M., Maki, R. G., Coindre, J., & Antonescu, C. R. (2012) · Cancer · doi:10.1002/cncr.27614 · Cited by 126
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma
Kwong, L. N., Boland, G. M., Frederick, D. T., Helms, T. L., Akid, A. T., Miller, J. P., Jiang, S., Cooper, Z. A., Song, X., Seth, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78954 · Cited by 120
Self-citation
MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor–Initiating Cells
Wang, X., Huang, Z., Wu, Q., Prager, B. C., Mack, S. C., Yang, K., Kim, L. J. Y., Gimple, R. C., Shi, Y., Lai, S., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0114 · Cited by 125
Pten and p53 Converge on c-Myc to Control Differentiation, Self-renewal, and Transformation of Normal and Neoplastic Stem Cells in GlioblastomaPreprint
Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., et al. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.047 · Cited by 122
Self-citation
Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2
Modrek, A. S., Golub, D., Khan, T. A., Bready, D., Prado, J., Bowman, C., Deng, J., Zhang, G., Rocha, P. P., Raviram, R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.009 · Cited by 118
Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas
Sutter, R., Shakhova, O., Bhagat, H., Behesti, H., Sutter, C., Penkar, S., Chadha, A. S., Bernays, R. L., Heppner, F. L., Schüller, U., et al. (2010) · Oncogene · doi:10.1038/onc.2009.472 · Cited by 113
Regulation of cell differentiation by the DNA damage response
Sherman, M. H., Bassing, C. H., & Teitell, M. A. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.01.004 · Cited by 119
Mutant IDH1 Promotes Glioma Formation In Vivo
Philip, B., Yu, D. X., Silvis, M. R., Shin, C., Robinson, J. P., Robinson, G. L., Welker, A., Angel, S. N., Tripp, S. R., Sonnen, J. A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.133 · Cited by 112
The tumor microenvironment: shaping cancer progression and treatment response
Desai, S. A., Patel, V. P., Bhosle, K. P., Nagare, S. D., & Thombare, K. C. (2025) · Journal of Chemotherapy · doi:10.1080/1120009x.2023.2300224 · Cited by 106
STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNAPreprint
Chen, A.-J., Paik, J.-H., Zhang, H., Shukla, S. A., Mortensen, R., HU, J. L., Ying, H., Hu, B., Hurt, J. A., Farny, N. G., et al. (2012) · Genes & Development · doi:10.1101/gad.189001.112 · Cited by 116
Self-citation
The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network
Boominathan, L. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9257-9 · Cited by 112
TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence
Li, K., Wang, F., Cao, W., Lv, X., Hua, F., Cui, B., Yu, J., Zhang, X., Shang, S., Liu, S., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.006 · Cited by 110
Neural Stem Cells of the Subventricular Zone as the Origin of Human Glioblastoma Stem Cells. Therapeutic Implications
Matarredona, E. R., & Pastor, Á. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00779 · Cited by 110
The role of microRNAs in glioma initiation and progression
Zhang, Y. (2011) · Frontiers in bioscience · doi:10.2741/3952 · Cited by 109
A STAT3-based gene signature stratifies glioma patients for targeted therapy
Tan, M. S. Y., Sandanaraj, E., Chong, Y. K., Lim, S. W., Koh, L., Ng, W. H., Tan, N. S., Tan, P. B. O., Ang, B. T., & Tang, C. (2019) · Nature Communications · doi:10.1038/s41467-019-11614-x · Cited by 109
Targeting Radiation-Induced G2 Checkpoint Activation with the Wee-1 Inhibitor MK-1775 in Glioblastoma Cell Lines
Sarcar, B., Kahali, S., Prabhu, A. H., Shumway, S. D., Xu, Y., Demuth, T., & Chinnaiyan, P. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0469 · Cited by 110
Culture conditions defining glioblastoma cells behavior: what is the impact for novel discoveries?
Ledur, P. F., Onzi, G. R., Zong, H., & Lenz, G. (2017) · Oncotarget · doi:10.18632/oncotarget.20193 · Cited by 106
The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy
Larsson, L., & Arsenian‐Henriksson, M. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.03.025 · Cited by 106
microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-β Signaling in Glioblastoma
Genovese, G., Ergün, A., Shukla, S. A., Campos, B., Hanna, J. A., Ghosh, P., Quayle, S. N., Rai, K., Colla, S., Ying, H., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0111 · Cited by 106
Self-citation
Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy
Patrizii, M., Bartucci, M., Pine, S. R., & Sabaawy, H. E. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00023 · Cited by 107
Dishevelled 2 Signaling Promotes Self-Renewal and Tumorigenicity in Human Gliomas
Pulvirenti, T., van der Heijden, M., Droms, L. A., Huse, J. T., Tabar, V. S., & Hall, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1531 · Cited by 103
Turning Cancer Stem Cells Inside Out: An Exploration of Glioma Stem Cell Signaling Pathways
Li, Z., Wang, H., Eyler, C. E., Hjelmeland, A. B., & Rich, J. N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r900013200 · Cited by 102
Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation
Shingu, T., Ho, A. L., Yuan, L., Zhou, X., Dai, C., Zheng, S., Wang, Q., Zhong, Y., Chang, Q., Horner, J. W., et al. (2016) · Nature Genetics · doi:10.1038/ng.3711 · Cited by 106
Pattern of invasion of the embryonic mouse spinal cord by microglial cells at the time of the onset of functional neuronal networks
Rigato, C., Buckinx, R., Corronc, H. L., Rigo, J., & Legendre, P. (2011) · Glia · doi:10.1002/glia.21140 · Cited by 102
Notching on Cancer’s Door: Notch Signaling in Brain Tumors
Teodorczyk, M., & Schmidt, M. H. H. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2014.00341 · Cited by 108
Thermally Targeted Delivery of a c-Myc Inhibitory Polypeptide Inhibits Tumor Progression and Extends Survival in a Rat Glioma Model
Bidwell, G. L., Perkins, E., Hughes, J. D., Khan, M., James, J. R., & Raucher, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055104 · Cited by 101
Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells
Sunayama, J., Satō, A., Matsuda, K., Tachibana, K., Suzuki, K., Narita, Y., Shibui, S., Sakurada, K., Kayama, T., Tomiyama, A., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq103 · Cited by 103
Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells
Wuputra, K., Ku, C., Wu, D., Lin, Y., Saito, S., & Yokoyama, K. K. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01584-0 · Cited by 103
Prostate Epithelial Pten/TP53 Loss Leads to Transformation of Multipotential Progenitors and Epithelial to Mesenchymal Transition
Martin, P., Liu, Y., Pierce, R. M., Abou-Kheir, W. G., Casey, O. M., Seng, V., Camacho, D. F., Simpson, R. J., & Kelly, K. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.035 · Cited by 100
Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells
Vázquez‐Martín, A., Vellón, L., Quirós, P. M., Cufí, S., de Galarreta, E. R., Oliveras‐Ferraros, C., Martín, Á. G., Martı́n-Castillo, B., López-Otı́n, C., & Menéndez, J. A. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19450 · Cited by 98
A practical review of prognostic correlations of molecular biomarkers in glioblastoma
Karsy, M. J., Neil, J. A., Guan, J., Mahan, M. A., Colman, H., & Jensen, R. L. (2015) · Neurosurgical FOCUS · doi:10.3171/2015.1.focus14755 · Cited by 98
Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis
Jaeckle, K. A., Decker, P. A., Ballman, K., Flynn, P. J., Giannini, C., Scheithauer, B. W., Jenkins, R. B., & Buckner, J. C. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0476-2 · Cited by 98
Pancreatic Cancer Stem Cells and Therapeutic Approaches
Ercan, G., Karlıtepe, A., & Özpolat, B. (2017) · Anticancer Research · doi:10.21873/anticanres.11628 · Cited by 97
p53 in neurodegenerative diseases and brain cancers
Checler, F., & da Costa, C. A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.009 · Cited by 99
Disruption of Trp53 in Livers of Mice Induces Formation of Carcinomas With Bilineal Differentiation
Katz, S., Lechel, A., Obenauf, A. C., Begus‐Nahrmann, Y., Kraus, J. M., Hoffmann, E. M., Duda, J., Eshraghi, P., Hartmann, D., Liss, B., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.009 · Cited by 96
Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells
Enane, F. O., Saunthararajah, Y., & Korc, M. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0919-9 · Cited by 96
Molecular Pathways: Rodent Parvoviruses—Mechanisms of Oncolysis and Prospects for Clinical Cancer Treatment
Nüesch, J. P. F., Lacroix, J., Marchini, A., & Rommelaere, J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2325 · Cited by 94
Mouse Models of p53 FunctionsPreprint
Lozano, G. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001115 · Cited by 97
Targeted Therapy for Malignant Glioma Patients: Lessons Learned and the Road Ahead
Huang, T., Sarkaria, S. M., Cloughesy, T. F., & Mischel, P. S. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.04.008 · Cited by 92
Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target
Wen, Y., Cai, J., Hou, Y., Huang, Z., & Wang, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.16467 · Cited by 91
Brain stem cells as the cell of origin in glioma
Modrek, A. S. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i1.43 · Cited by 90
The Role of Inflammation in Brain Cancer
Sowers, J. L., Johnson, K. M., Conrad, C. C., Patterson, J. T., & Sowers, L. C. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-0348-0837-8_4 · Cited by 93
Drosophila melanogaster as a model system for human brain cancers
Read, R. D. (2011) · Glia · doi:10.1002/glia.21148 · Cited by 92
Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss
Medyouf, H., Gao, X., Armstrong, F., Gusscott, S., Liu, Q., Gedman, A. L., Matherly, L. H., Schultz, K. R., Pflumio, F., You, M. J., et al. (2009) · Blood · doi:10.1182/blood-2009-04-214718 · Cited by 89
Self-citation
Monoamines in glioblastoma: complex biology with therapeutic potential
Caragher, S. P., Hall, R. R., Ahsan, R., & Ahmed, A. U. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox210 · Cited by 91
Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile
Hägerstrand, D., He, X., Lindh, M. B., Hoefs, S., Hesselager, G., Östman, A., & Nistér, M. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor113 · Cited by 93
The Regulation of Aging and Longevity: A New and Complex Role of p53
Feng, Z., Lin, M., & Wu, R. (2011) · Genes & Cancer · doi:10.1177/1947601911410223 · Cited by 88
Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells
Hu, J. X., Wang, J., Wang, G., Yao, Z., & Dang, X. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2458 · Cited by 87
Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressorPreprint
Stegh, A. H., Brennan, C., Mahoney, J. E., Forloney, K. L., Jenq, H. T., Luciano, J. P., Protopopov, A. I., Chin, L., & DePinho, R. A. (2010) · Genes & Development · doi:10.1101/gad.1924710 · Cited by 88
Self-citation
p53 in stem cells
Solozobova, V. (2011) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v2.i9.202 · Cited by 87
Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression
Kozono, D., Li, J., Nitta, M., Sampetrean, O., Gonda, D. D., Kushwaha, D. S., Merzon, D., Ramakrishnan, V., Zhu, S., Zhu, K., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501967112 · Cited by 84
The origins of glioma: E Pluribus Unum?
Siebzehnrübl, F. A., Reynolds, B. A., Vescovi, A. L., Steindler, D. A., & Deleyrolle, L. P. (2011) · Glia · doi:10.1002/glia.21143 · Cited by 91
Interactions between Cells with Distinct Mutations in c-MYC and Pten in Prostate Cancer
Kim, J., Eltoum, I., Roh, M., Wang, J., & Abdulkadir, S. A. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000542 · Cited by 88
Machine Learning Versus Logistic Regression Methods for 2-Year Mortality Prognostication in a Small, Heterogeneous Glioma Database
Panesar, S. S., D’souza, R. N., Yeh, F.-C. F., & Fernandez-Miranda, J. C. (2019) · World Neurosurgery X · doi:10.1016/j.wnsx.2019.100012 · Cited by 83
Cell death and neuronal differentiation of glioblastoma stem‐like cells induced by neurogenic transcription factors
Guichet, P., Bièche, I., Teigell, M., Serguera, C., Rothhut, B., Rigau, V., Scamps, F., Ripoll, C., Vacher, S., Taviaux, S. A., et al. (2012) · Glia · doi:10.1002/glia.22429 · Cited by 89
Intratumoral Mediated Immunosuppression is Prognostic in Genetically Engineered Murine Models of Glioma and Correlates to Immunotherapeutic Responses
Kong, L.-Y., Wu, A., Doucette, T. A., Wei, J., Priebe, W., Fuller, G. N., Qiao, W., Sawaya, R. A., Rao, G., & Heimberger, A. B. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1693 · Cited by 80
FoxM1B Regulates NEDD4-1 Expression, Leading to Cellular Transformation and Full Malignant Phenotype in Immortalized Human Astrocytes
Dai, B., Pieper, R. O., Li, D., Wei, P., Liu, M., Woo, S. Y., Aldape, K., Sawaya, R. A., Xie, K., & Huang, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3909 · Cited by 80
Cancer Stem Cells in Brain Tumor BiologyPreprint
Rich, J. N., & Eyler, C. E. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.060 · Cited by 80
The REST remodeling complex protects genomic integrity during embryonic neurogenesis
Nechiporuk, T., McGann, J. C., Müllendorff, K., Hsieh, J., Wurst, W., Floß, T., & Mandel, G. (2016) · eLife · doi:10.7554/elife.09584 · Cited by 81
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway
Wen, N., Guo, B., Zheng, H., Xu, L., Liang, H., Wang, Q., Wang, D., Chen, X., Zhang, S., Li, Y., et al. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4863 · Cited by 79
Self-citation
Promoting brain remodeling to aid in stroke recovery
Zhang, Z. G., & Chopp, M. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.07.005 · Cited by 78
Neutralization of terminal differentiation in gliomagenesis
Hu, J., Ho, A. L., Yuan, L., Hu, B., Hua, S., Hwang, S. S., Zhang, J., Hu, T., Zheng, H., Gan, B., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308610110 · Cited by 76
Self-citation
A Review of Radiomics and Deep Predictive Modeling in Glioma Characterization
Gore, S. A., Chougule, T., Jagtap, J., Saini, J. S., & Ingalhalikar, M. (2020) · Academic Radiology · doi:10.1016/j.acra.2020.06.016 · Cited by 80
Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation
Gopisetty, G., Xu, J., Sampath, D., Colman, H., & Puduvalli, V. K. (2012) · Oncogene · doi:10.1038/onc.2012.331 · Cited by 77
Cancer Stemness: p53 at the Wheel
Ghatak, D., Ghosh, D. D., & Roychoudhury, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.604124 · Cited by 75
Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells
Bartesaghi, S., Graziano, V., Galavotti, S., Henriquez, N. V., Betts, J., Saxena, J., Minieri, V., Deli, A., Karlsson, A., Martins, L. M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413165112 · Cited by 75
Vertebrate animal models of glioma: Understanding the mechanisms and developing new therapies
Chen, L. L., Zhang, Y., Yang, J., Hagan, J. P., & Li, M. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.04.003 · Cited by 74
SMYD3: a regulator of epigenetic and signaling pathways in cancer
Bernard, B., Nigam, N., Burkitt, K., & Saloura, V. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01021-9 · Cited by 76
Circular RNA encoded MET variant promotes glioblastoma tumorigenesis
Zhong, J., Wu, X., Gao, Y., Chen, J., Zhang, M., Zhou, H., Yang, J., Xiao, F., Yang, X., Huang, N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40212-1 · Cited by 73
The C terminus of p53 regulates gene expression by multiple mechanisms in a target- and tissue-specific manner in vivoPreprint
Hamard, P.-J., Barthelery, N. J., Hogstad, B., Mungamuri, S. K., Tonnessen-Murray, C. A., Carvajal, L. A., Senturk, E., Gillespie, V., Aaronson, S. A., Mérad, M., et al. (2013) · Genes & Development · doi:10.1101/gad.224386.113 · Cited by 79
Beyond effector caspase inhibition
Stegh, A. H., & DePinho, R. A. (2011) · Cell Cycle · doi:10.4161/cc.10.1.14365 · Cited by 72
Self-citation
EGFR/c-myc axis regulates TGFβ/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomas
Zhao, K., Wang, Q., Wang, Y., Huang, K., Yang, C., Li, Y., Yi, K., & Kang, C. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.022 · Cited by 73
Self-citation
MicroRNAs in Cerebral Ischemia-Induced Neurogenesis
Liu, X., Chopp, M., Zhang, R. L., & Zhang, Z. G. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31829e4963 · Cited by 71
p53 connects tumorigenesis and reprogramming to pluripotency
Tàpia, N., & Schöler, H. R. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101866 · Cited by 71
Cancer stem cells: a potential target for cancer therapy
Qiu, H. Y., Fang, X., Luo, Q., & Ouyang, G. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1920-4 · Cited by 72
p53 Loss Increases the Osteogenic Differentiation of Bone Marrow Stromal Cells
He, Y., de Castro, L. F., Shin, M. H., Dubois, W., Yang, H. H., Jiang, S., Mishra, P. J., Ren, L., Gou, H., Lal, A., et al. (2014) · Stem Cells · doi:10.1002/stem.1925 · Cited by 72
Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression
Guerrero, P. A., Tchaicha, J. H., Chen, Z., Morales, J. E., McCarty, N., Wang, Q., Sulman, E. P., Fuller, G. N., Lang, F. F., Rao, G., et al. (2017) · Oncogene · doi:10.1038/onc.2017.248 · Cited by 70
p53 Regulates Neural Stem Cell Proliferation and Differentiation via BMP-Smad1 Signaling and Id1
Liu, H., Jia, D., Li, A., Chau, J. F. L., He, D. N., Ruan, X., Liu, F., Li, J., He, L., & Li, B. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0370 · Cited by 69
Glioblastoma Multiforme Formation and EMT: Role of FoxM1 Transcription Factor
Wang, Z., Zhang, S., Siu, T. L. T., & Huang, S. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666141211115949 · Cited by 69
Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway
Sai, K., Wang, S., Balasubramaniyan, V., Conrad, C. A., Lang, F. F., Aldape, K., Szymański, S., Fokt, I., Dasgupta, A., Madden, T. L., et al. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0786-z · Cited by 69
AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis
Kircher, D. A., Trombetti, K. A., Silvis, M. R., Parkman, G. L., Fischer, G. M., Angel, S. N., Stehn, C. M., Strain, S. C., Grossmann, A. H., Duffy, K. L., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1372 · Cited by 70

Authors: Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., Stommel, J. M., Dunn, K. L., Wiedemeyer, R., You, M. J., Brennan, C., Wang, Y. A., Ligon, K. L., Wong, W. H., Chin, L., & DePinho, R. A.
Affiliations: Harvard University (US)
Stanford University (US)
Memorial Sloan Kettering Cancer Center (US)
Brigham and Women's Hospital (US)
Corresponding author: DePinho, Ronald A.
ORCID: Zheng, Hongwu
Ying, Haoqiang
Yan, Haiyan
Kimmelman, Alec C.
Hiller, David J.
Tonon, Giovanni
Stommel, Jayne M.
Dunn, Katherine L.
You, Mingjian J.
Brennan, Cameron
Wang, Y. Alan
Ligon, Keith L.
Wong, Wing H.
DePinho, Ronald A.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2008-10
Volume: 455
Issue: 7216
Pages: 1129-1133
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature07443
PMC: PMC4051433
OpenAlex: W2109610561
Cited by: 767
References: 37
Citations by year: 2026: 12 · 2025: 20 · 2024: 32 · 2023: 41 · 2022: 33 · 2021: 32 · 2020: 41 · 2019: 33 · 2018: 35 · 2017: 38 · 2016: 39 · 2015: 46 · 2014: 47 · 2013: 61 · 2012: 76
FWCI: 27.60
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
RePEc: Research Papers in Economics (submittedVersion)
Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
Funders: National Cancer Institute (R01 CA99041, R01CA099041, U01CA84313, 5P01CA95616, U01CA084313, P01CA095616)
Topics: Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords: p53, PTEN, glioblastoma, neural stem cells, glioma stem cells, c-Myc, tumor suppressor inactivation, cell differentiation, cell renewal, TP53 mutation, PTEN mutation, gene expression profiling, promoter analysis, EGFR, neurofibromatosis type 1, RB1, ATM, APC
MeSH terms: Animals, Brain Neoplasms, Cell Differentiation, Gene Expression Regulation, Glioblastoma, Glioma, Humans, Immunohistochemistry, Neurons, Neoplastic Stem Cells, Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-myc, Cell Proliferation, PTEN Phosphohydrolase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks